在"悦己经济"与"情感消费"浪潮驱动下，"它经济"正不断释放潜力：2024年我国城镇宠物猫达7153万 只、宠物狗达5258万只，城镇宠物（犬猫）市场规模超3000亿元，预计2027年将冲刺4000亿元大关。随 着养宠主力军呈现年轻化、高学历化特征，"宠物即家庭成员"的消费观念又推动市场从"量"的扩张转 向"质"的深耕，逐步向医疗等高附加值产业链辐射。而在2025年亚洲宠物展览会（以下简称"亚宠展"） 上，新华财经观察到，作为医疗生态关键一环的宠物药市场正经历深刻的结构性变革。 白热化竞争格局 全球动保（动物保护）行业的业务结构分布，已为市场发展趋势划定清晰轨迹。跨国动保企业勃林格殷 格翰披露，当前其全球动保业务中，伴侣动物业务占比达67%，显著高于畜禽业务的33%。以其为代 表，欧美发达国家动保市场普遍呈现相似的业务结构特征。这种"宠物业务为主、禽畜业务为辅"的格局 并非偶然，而是成熟市场"宠物拟人化"消费趋势的必然结果——宠物药市场成为动保行业的增量板块， 也由此确立了"宠物经济主导"的全球行业基准。 反观中国市场，目前仍以畜禽业务为主导、宠物业务占比尚低，与欧美等发达市场形成显著差异。不 过，国内企业已 ...

8月20日—24日，第27届亚洲宠物展览会在上海举行。海正药业（600267）子公司海正动保携驱虫、疫 苗及保健护理等全线产品亮相，重点展出海乐妙、海乐旺、莫爱佳、喜倍安、赛乐滴等多款明星产品， 主要布局驱虫药与疫苗领域。 海正动保是知名药企海正药业全资子公司，成立于2009年8月。海正药业动物药业务起源于1992年，原 聚焦于经济动物领域，后转向宠物药主导，并主要通过旗下子公司海正动保进行重点布局。 其中，"海乐妙"为海正动保旗下拳头产品，也是国产首款猫用复方驱虫片剂。今年正值"海乐妙"上市10 周年，十年间，海乐妙成为首个销售额突破1亿元的国产驱虫药，累计销量超过4500万片。据海正动保 总经理冀伟介绍，从海乐妙一枝独秀，到如今"驱虫口服药+滴剂+疫苗"的大预防产品矩阵，海正动保 已构建覆盖宠物全生命周期健康管理的完整产品线。 目前，海正动保以多品牌构建驱虫药产品矩阵，已实现6种进口宠物驱虫药的国产替代，其中国产首款 犬猫体内外同驱滴剂赛乐滴等产品，彰显了品牌创新实力。同时，海正动保积极布局宠物疫苗领域，今 年与华中农业大学农业微生物资源发掘与利用全国重点实验室联合研发的首款猫三联疫苗"海妙哆"正式 推出 ...

Core Viewpoint - The transformation of the Changzhou Binjiang Economic Development Zone from a chemical industry hub to an eco-friendly and innovative industrial area demonstrates the successful integration of ecological restoration and economic development [8]. Group 1: Environmental Transformation - The Changzhou section of the Yangtze River has seen a significant ecological transformation, with 45 out of 84 chemical enterprises dismantled, resulting in over 3,600 acres of land being restored, achieving an ecological shoreline ratio of 80.6% [1][2]. - The area has established a "Changzhou Path" for ecological restoration, which includes a full process of "enterprise retreat - soil remediation - ecological restoration," leading to a harmonious coexistence of ecology and production [3][4]. Group 2: Economic Growth and Industrial Transition - The chemical industry output in the Binjiang Economic Development Zone has increased by 45% over five years, with per-acre tax revenue rising from 111,000 yuan to 480,000 yuan, showcasing the vitality of green transformation [3][4]. - Companies like Changmao Biochemical Engineering Co., Ltd. have shifted focus from traditional chemical production to green food and feed additives, achieving a record annual sales revenue of 657 million yuan [3][5]. Group 3: New Industry Development - The establishment of new projects, such as the carbon fiber production base with a total investment of 5 billion yuan, highlights the area's shift towards high-tech industries [5]. - The pharmaceutical sector is also thriving, with companies like Qihui Pharmaceutical investing nearly 200 million yuan to pivot towards pet medicine, resulting in a 40% year-on-year sales increase in the first half of the year [6]. Group 4: Community and Cultural Impact - The ecological improvements have enhanced the quality of life for local residents, with increased tourism and recreational activities along the river, contributing to a sense of community well-being [7]. - The development of the Changzhou Yangtze National Cultural Park has transformed former industrial sites into cultural and recreational hubs, attracting visitors and boosting local economy [7][8].